Actionable news
0
All posts from Actionable news
Actionable news in ITCI: INTRA-CELLULAR THERAPIES Inc,

After-hours buzz: ITCI, FIZZ, PIR & more

Check out which companies are making headlines after the bell on Wednesday:

Intra-Cellular Therapies plummeted 69 percent after the market closed Wednesday. The biopharmaceutical company announced top-line results from the second phase 3 clinical trial on a treatment for schizophrenia. The medicine at the center of the trial, ITI-007, "did not separate from the placebo ... in part due to an unusually high placebo response."

"We plan to request a meeting with the U.S. Food and Drug Administration's Division of...


More